EyePoint Pharmaceuticals, Inc.

2 marketed · 1 in Phase 3

Quick facts

Marketed products

Dexycu · Other
Prednisolone Acetate Ophthalmic

Phase 3 pipeline

EYP-1901 · Ophthalmology
EYP-1901 is a sustained-release corticosteroid implant designed to deliver anti-inflammatory therapy directly to the eye.

Phase 2 pipeline